Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors
Streptococcus pneumoniae is an important human pathogen and the most common cause of community-acquired pneumonia. Both adaptive and innate immune mechanisms provide protection from infection. Innate immunity to S. pneumoniae in mice is mediated by naturally occurring anti-phosphocholine (PC) Abs an...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2002-06, Vol.168 (12), p.6375-6381 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6381 |
---|---|
container_issue | 12 |
container_start_page | 6375 |
container_title | The Journal of immunology (1950) |
container_volume | 168 |
creator | Mold, Carolyn Rodic-Polic, Bojana Du Clos, Terry W |
description | Streptococcus pneumoniae is an important human pathogen and the most common cause of community-acquired pneumonia. Both adaptive and innate immune mechanisms provide protection from infection. Innate immunity to S. pneumoniae in mice is mediated by naturally occurring anti-phosphocholine (PC) Abs and complement. The human acute-phase reactant C-reactive protein (CRP) also protects mice from lethal S. pneumoniae infection. CRP and anti-PC Ab share the ability to bind to PC on the cell wall C-polysaccharide of S. pneumoniae and to activate complement. CRP and IgG anti-PC also bind to Fc gamma R. In this study, Fc gamma R- and complement-deficient mice were used to compare the mechanisms of protection conferred by CRP and anti-PC Ab. Injection of CRP protected wild-type, FcR gamma-chain-, Fc gamma RIIb-, and Fc gamma RIII-deficient mice from infection. Complement was required for the protective effect of CRP as cobra venom factor treatment eliminated the effect of CRP in both gamma-chain-deficient and wild-type mice, and CRP failed to protect C3- or C4-deficient mice from infection. Unexpectedly, gamma-chain-deficient mice were extremely sensitive to pneumococcal infection. This sensitivity was associated with low levels of natural anti-PC Ab. Gamma-chain-deficient mice immunized with nonencapsulated S. pneumoniae produced both IgM- and IgG PC-specific Abs, were protected from infection, and were able to clear the bacteria from the bloodstream. The protection provided by immunization was eliminated by complement depletion. The results show that in this model of systemic infection with highly virulent S. pneumoniae, protection from lethality by CRP and anti-PC Abs requires complement, but not Fc gamma R. |
doi_str_mv | 10.4049/jimmunol.168.12.6375 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71802676</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18422993</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-b0d2ed116aff2e5237febf58c95c4a2445a3416e83b6b45e3805823ecb5f89903</originalsourceid><addsrcrecordid>eNqFkU1rFEEQhhtRzCbxH4j0ydus_T0zR1mMCQQUNOemu6daJkx3T_pD2P_gj3aWrOToqargqbcKHoTeU7IXRIyfHucQWkzLnqphT9le8V6-QjsqJemUIuo12hHCWEd71V-gy1IeCSGKMPEWXVBGpGRS7tCf7zlVcHVOEfucAv5RM6w1ueRcK3iN0EKKswE8R3_m7BEfugxmm34DXk8Bc8QmTjia2rJZtr7ONk1HnOGpzRkKdimsCwSIFdtWcUwV3zj8y4RgNsidTuZyjd54sxR4d65X6OHmy8_DbXf_7evd4fN95zgXtbNkYjBRqoz3DCTjvQfr5eBG6YRhQkjDBVUwcKuskMAHIgfGwVnph3Ek_Ap9fM7dfn9qUKoOc3GwLCZCakX3dCBM9eq_IB0EY-PIN1A8gy6nUjJ4veY5mHzUlOiTLv1Pl950acr0Sde29uGc32yA6WXp7If_BfJ7lwY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18422993</pqid></control><display><type>article</type><title>Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mold, Carolyn ; Rodic-Polic, Bojana ; Du Clos, Terry W</creator><creatorcontrib>Mold, Carolyn ; Rodic-Polic, Bojana ; Du Clos, Terry W</creatorcontrib><description>Streptococcus pneumoniae is an important human pathogen and the most common cause of community-acquired pneumonia. Both adaptive and innate immune mechanisms provide protection from infection. Innate immunity to S. pneumoniae in mice is mediated by naturally occurring anti-phosphocholine (PC) Abs and complement. The human acute-phase reactant C-reactive protein (CRP) also protects mice from lethal S. pneumoniae infection. CRP and anti-PC Ab share the ability to bind to PC on the cell wall C-polysaccharide of S. pneumoniae and to activate complement. CRP and IgG anti-PC also bind to Fc gamma R. In this study, Fc gamma R- and complement-deficient mice were used to compare the mechanisms of protection conferred by CRP and anti-PC Ab. Injection of CRP protected wild-type, FcR gamma-chain-, Fc gamma RIIb-, and Fc gamma RIII-deficient mice from infection. Complement was required for the protective effect of CRP as cobra venom factor treatment eliminated the effect of CRP in both gamma-chain-deficient and wild-type mice, and CRP failed to protect C3- or C4-deficient mice from infection. Unexpectedly, gamma-chain-deficient mice were extremely sensitive to pneumococcal infection. This sensitivity was associated with low levels of natural anti-PC Ab. Gamma-chain-deficient mice immunized with nonencapsulated S. pneumoniae produced both IgM- and IgG PC-specific Abs, were protected from infection, and were able to clear the bacteria from the bloodstream. The protection provided by immunization was eliminated by complement depletion. The results show that in this model of systemic infection with highly virulent S. pneumoniae, protection from lethality by CRP and anti-PC Abs requires complement, but not Fc gamma R.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.168.12.6375</identifier><identifier>PMID: 12055255</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Antibodies, Bacterial - biosynthesis ; Antibodies, Bacterial - physiology ; C-Reactive Protein - administration & dosage ; C-Reactive Protein - therapeutic use ; Complement Pathway, Classical - genetics ; Complement Pathway, Classical - immunology ; Complement System Proteins - physiology ; Female ; Genetic Predisposition to Disease ; Humans ; Immunity, Innate - genetics ; Immunoglobulin M - biosynthesis ; Immunoglobulin M - physiology ; Injections, Intravenous ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Phosphorylcholine - administration & dosage ; Phosphorylcholine - immunology ; Pneumococcal Infections - genetics ; Pneumococcal Infections - immunology ; Pneumococcal Infections - prevention & control ; Polysaccharides, Bacterial - administration & dosage ; Polysaccharides, Bacterial - immunology ; Receptors, IgG - deficiency ; Receptors, IgG - genetics ; Receptors, IgG - physiology</subject><ispartof>The Journal of immunology (1950), 2002-06, Vol.168 (12), p.6375-6381</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-b0d2ed116aff2e5237febf58c95c4a2445a3416e83b6b45e3805823ecb5f89903</citedby><cites>FETCH-LOGICAL-c334t-b0d2ed116aff2e5237febf58c95c4a2445a3416e83b6b45e3805823ecb5f89903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12055255$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mold, Carolyn</creatorcontrib><creatorcontrib>Rodic-Polic, Bojana</creatorcontrib><creatorcontrib>Du Clos, Terry W</creatorcontrib><title>Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Streptococcus pneumoniae is an important human pathogen and the most common cause of community-acquired pneumonia. Both adaptive and innate immune mechanisms provide protection from infection. Innate immunity to S. pneumoniae in mice is mediated by naturally occurring anti-phosphocholine (PC) Abs and complement. The human acute-phase reactant C-reactive protein (CRP) also protects mice from lethal S. pneumoniae infection. CRP and anti-PC Ab share the ability to bind to PC on the cell wall C-polysaccharide of S. pneumoniae and to activate complement. CRP and IgG anti-PC also bind to Fc gamma R. In this study, Fc gamma R- and complement-deficient mice were used to compare the mechanisms of protection conferred by CRP and anti-PC Ab. Injection of CRP protected wild-type, FcR gamma-chain-, Fc gamma RIIb-, and Fc gamma RIII-deficient mice from infection. Complement was required for the protective effect of CRP as cobra venom factor treatment eliminated the effect of CRP in both gamma-chain-deficient and wild-type mice, and CRP failed to protect C3- or C4-deficient mice from infection. Unexpectedly, gamma-chain-deficient mice were extremely sensitive to pneumococcal infection. This sensitivity was associated with low levels of natural anti-PC Ab. Gamma-chain-deficient mice immunized with nonencapsulated S. pneumoniae produced both IgM- and IgG PC-specific Abs, were protected from infection, and were able to clear the bacteria from the bloodstream. The protection provided by immunization was eliminated by complement depletion. The results show that in this model of systemic infection with highly virulent S. pneumoniae, protection from lethality by CRP and anti-PC Abs requires complement, but not Fc gamma R.</description><subject>Animals</subject><subject>Antibodies, Bacterial - biosynthesis</subject><subject>Antibodies, Bacterial - physiology</subject><subject>C-Reactive Protein - administration & dosage</subject><subject>C-Reactive Protein - therapeutic use</subject><subject>Complement Pathway, Classical - genetics</subject><subject>Complement Pathway, Classical - immunology</subject><subject>Complement System Proteins - physiology</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Immunity, Innate - genetics</subject><subject>Immunoglobulin M - biosynthesis</subject><subject>Immunoglobulin M - physiology</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Phosphorylcholine - administration & dosage</subject><subject>Phosphorylcholine - immunology</subject><subject>Pneumococcal Infections - genetics</subject><subject>Pneumococcal Infections - immunology</subject><subject>Pneumococcal Infections - prevention & control</subject><subject>Polysaccharides, Bacterial - administration & dosage</subject><subject>Polysaccharides, Bacterial - immunology</subject><subject>Receptors, IgG - deficiency</subject><subject>Receptors, IgG - genetics</subject><subject>Receptors, IgG - physiology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1rFEEQhhtRzCbxH4j0ydus_T0zR1mMCQQUNOemu6daJkx3T_pD2P_gj3aWrOToqargqbcKHoTeU7IXRIyfHucQWkzLnqphT9le8V6-QjsqJemUIuo12hHCWEd71V-gy1IeCSGKMPEWXVBGpGRS7tCf7zlVcHVOEfucAv5RM6w1ueRcK3iN0EKKswE8R3_m7BEfugxmm34DXk8Bc8QmTjia2rJZtr7ONk1HnOGpzRkKdimsCwSIFdtWcUwV3zj8y4RgNsidTuZyjd54sxR4d65X6OHmy8_DbXf_7evd4fN95zgXtbNkYjBRqoz3DCTjvQfr5eBG6YRhQkjDBVUwcKuskMAHIgfGwVnph3Ek_Ap9fM7dfn9qUKoOc3GwLCZCakX3dCBM9eq_IB0EY-PIN1A8gy6nUjJ4veY5mHzUlOiTLv1Pl950acr0Sde29uGc32yA6WXp7If_BfJ7lwY</recordid><startdate>20020615</startdate><enddate>20020615</enddate><creator>Mold, Carolyn</creator><creator>Rodic-Polic, Bojana</creator><creator>Du Clos, Terry W</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20020615</creationdate><title>Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors</title><author>Mold, Carolyn ; Rodic-Polic, Bojana ; Du Clos, Terry W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-b0d2ed116aff2e5237febf58c95c4a2445a3416e83b6b45e3805823ecb5f89903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antibodies, Bacterial - biosynthesis</topic><topic>Antibodies, Bacterial - physiology</topic><topic>C-Reactive Protein - administration & dosage</topic><topic>C-Reactive Protein - therapeutic use</topic><topic>Complement Pathway, Classical - genetics</topic><topic>Complement Pathway, Classical - immunology</topic><topic>Complement System Proteins - physiology</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Immunity, Innate - genetics</topic><topic>Immunoglobulin M - biosynthesis</topic><topic>Immunoglobulin M - physiology</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Phosphorylcholine - administration & dosage</topic><topic>Phosphorylcholine - immunology</topic><topic>Pneumococcal Infections - genetics</topic><topic>Pneumococcal Infections - immunology</topic><topic>Pneumococcal Infections - prevention & control</topic><topic>Polysaccharides, Bacterial - administration & dosage</topic><topic>Polysaccharides, Bacterial - immunology</topic><topic>Receptors, IgG - deficiency</topic><topic>Receptors, IgG - genetics</topic><topic>Receptors, IgG - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mold, Carolyn</creatorcontrib><creatorcontrib>Rodic-Polic, Bojana</creatorcontrib><creatorcontrib>Du Clos, Terry W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mold, Carolyn</au><au>Rodic-Polic, Bojana</au><au>Du Clos, Terry W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2002-06-15</date><risdate>2002</risdate><volume>168</volume><issue>12</issue><spage>6375</spage><epage>6381</epage><pages>6375-6381</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Streptococcus pneumoniae is an important human pathogen and the most common cause of community-acquired pneumonia. Both adaptive and innate immune mechanisms provide protection from infection. Innate immunity to S. pneumoniae in mice is mediated by naturally occurring anti-phosphocholine (PC) Abs and complement. The human acute-phase reactant C-reactive protein (CRP) also protects mice from lethal S. pneumoniae infection. CRP and anti-PC Ab share the ability to bind to PC on the cell wall C-polysaccharide of S. pneumoniae and to activate complement. CRP and IgG anti-PC also bind to Fc gamma R. In this study, Fc gamma R- and complement-deficient mice were used to compare the mechanisms of protection conferred by CRP and anti-PC Ab. Injection of CRP protected wild-type, FcR gamma-chain-, Fc gamma RIIb-, and Fc gamma RIII-deficient mice from infection. Complement was required for the protective effect of CRP as cobra venom factor treatment eliminated the effect of CRP in both gamma-chain-deficient and wild-type mice, and CRP failed to protect C3- or C4-deficient mice from infection. Unexpectedly, gamma-chain-deficient mice were extremely sensitive to pneumococcal infection. This sensitivity was associated with low levels of natural anti-PC Ab. Gamma-chain-deficient mice immunized with nonencapsulated S. pneumoniae produced both IgM- and IgG PC-specific Abs, were protected from infection, and were able to clear the bacteria from the bloodstream. The protection provided by immunization was eliminated by complement depletion. The results show that in this model of systemic infection with highly virulent S. pneumoniae, protection from lethality by CRP and anti-PC Abs requires complement, but not Fc gamma R.</abstract><cop>United States</cop><pmid>12055255</pmid><doi>10.4049/jimmunol.168.12.6375</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | The Journal of immunology (1950), 2002-06, Vol.168 (12), p.6375-6381 |
issn | 0022-1767 1550-6606 |
language | eng |
recordid | cdi_proquest_miscellaneous_71802676 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Antibodies, Bacterial - biosynthesis Antibodies, Bacterial - physiology C-Reactive Protein - administration & dosage C-Reactive Protein - therapeutic use Complement Pathway, Classical - genetics Complement Pathway, Classical - immunology Complement System Proteins - physiology Female Genetic Predisposition to Disease Humans Immunity, Innate - genetics Immunoglobulin M - biosynthesis Immunoglobulin M - physiology Injections, Intravenous Male Mice Mice, Inbred C57BL Mice, Knockout Phosphorylcholine - administration & dosage Phosphorylcholine - immunology Pneumococcal Infections - genetics Pneumococcal Infections - immunology Pneumococcal Infections - prevention & control Polysaccharides, Bacterial - administration & dosage Polysaccharides, Bacterial - immunology Receptors, IgG - deficiency Receptors, IgG - genetics Receptors, IgG - physiology |
title | Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T06%3A51%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Protection%20from%20Streptococcus%20pneumoniae%20infection%20by%20C-reactive%20protein%20and%20natural%20antibody%20requires%20complement%20but%20not%20Fc%20gamma%20receptors&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Mold,%20Carolyn&rft.date=2002-06-15&rft.volume=168&rft.issue=12&rft.spage=6375&rft.epage=6381&rft.pages=6375-6381&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.168.12.6375&rft_dat=%3Cproquest_cross%3E18422993%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18422993&rft_id=info:pmid/12055255&rfr_iscdi=true |